Ikarian Capital, LLC Eye Point Pharmaceuticals, Inc. Call Options Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$19.93 - $29.71 $3.68 Million - $5.48 Million	-184,500 Reduced 47.19%	206,500 $4.27 Million
Q4 2023 Feb 14, 2024	BUY	$5.71 - $24.13 $2.23 Million - $9.43 Million	391,000 New	391,000 $9.04 Million
Q1 2021 May 17, 2021	BUY	$8.89 - $14.92 $1.69 Million - $2.84 Million	190,600 Added 1064.8%	208,500 $2.12 Million
Q4 2020 Feb 12, 2021	BUY	$3.7 - $6.58 $66,230 - $117,782	17,900 New	17,900 $119,000

154

58.2M

177K

263K

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $263M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.